Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 35: NACI statement: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age [2022-03-17]”. NACI recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age: methods, vaccine recommendations, schedule, clinical trial data and solicited adverse events following immunization for COVID-19.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.